Acceleration of diabetic‐wound healing with PEGylated rhaFGF in healing‐impaired streptozocin diabetic rats
- 30 September 2011
- journal article
- Published by Wiley in Wound Repair and Regeneration
- Vol. 19 (5), 633-644
- https://doi.org/10.1111/j.1524-475x.2011.00722.x
Abstract
Molecular modification with polyethylene glycol (PEGylation) is an effective approach to improve protein biostability, in vivo lifetime and therapeutic potency. In the present study, the recombinant human acid fibroblast growth factor (rhaFGF) was site-selectively PEGylated with 20 kDa mPEG-butyraldehyde. Mono-PEGylated rhaFGF was purified to near homogeneity by Sephadex G 25-gel filtration followed by a Heparin Sepharose TM CL-6B affinity chromatography. PEGylated rhaFGF has less effect than the native rhaFGF on the stimulation of 3T3 cell proliferation in vitro; however, its relative thermal stability at normal physiological temperature and structural stability were significantly enhanced, and its half-life time in vivo was significantly extended. Then, the physiological function of PEGylated rhaFGF on diabetic-wound healing was evaluated in type 1 diabetic Sprague Dawley rats. The results showed that, compared with the group of animal treated with native rhaFGF, the group treated with PEGylated rhaFGF exhibited better therapeutic efficacy with shorter healing time, quicker tissue collagen generation, earlier and higher transforming growth factor (TGF)-β expression, and dermal cell proliferation. In addition, in vivo analysis showed that both native and PEGylated rhaFGF were more effective in the wound healing in the diabetic group compared with the nondiabetic one. Taken together, these results suggest that PEGylation of rhaFGF could be a more effective approach to the pharmacological and therapeutic application of native rhaFGF.Keywords
This publication has 30 references indexed in Scilit:
- Chemical modification of recombinant human keratinocyte growth factor 2 with polyethylene glycol improves biostability and reduces animal immunogenicityJournal of Biotechnology, 2009
- Inflammation and neuropeptides: the connection in diabetic wound healingExpert Reviews in Molecular Medicine, 2009
- Solid-Phase PEGylation of Recombinant Interferon α-2a for Site-Specific Modification: Process Performance, Characterization, andin VitroBioactivityBioconjugate Chemistry, 2007
- Cellular and molecular basis of wound healing in diabetesJCI Insight, 2007
- Chemokines, cytokines, and growth factors in keratinocytes and dermal endothelial cells in the margin of chronic diabetic foot ulcersWound Repair and Regeneration, 2006
- Pharmacokinetic and biodistribution properties of poly(ethylene glycol)–protein conjugatesAdvanced Drug Delivery Reviews, 2003
- A Role for Skin γδ T Cells in Wound RepairScience, 2002
- Angiogenesis induced by acidic fibroblast growth factor as an alternative method of revascularization for chronic myocardial ischemiaSurgery, 1996
- Biomedical and biotechnological applications of PEG- and PM-modified proteinsTrends in Biotechnology, 1995
- Polyethylene glycol modification of the monoclonal antibody A7 enhances its tumor localizationBiochemical and Biophysical Research Communications, 1990